Related Experiment Videos
Domperidone plus pinaverium bromide and itopride for functional dyspepsia in the elderly: efficacy, symptom
Chuang Yang1, Weijun Zhu1, Heyan Guan1
1Department of Gastroenterology, Guannan County First People's Hospital Lianyungang 222500, Jiangsu, China.
Objective:
Focusing on functional dyspepsia (FD) in the elderly, this study analyzes how the triple therapy consisting of domperidone (DPD), pinaverium bromide (PB), and itopride (ITP) impacts curative efficacy, symptom amelioration, and the gastric function (GF) panel.
Methods:
A total of 96 elderly FD adults were selected and allocated to a control group treated with PB+ITP or a research group which additionally received DPD in addition to PB+ITP. Outcome measures included curative efficacy, symptom amelioration, gastric accommodation, electrogastrographic parameters (dominant frequency, dominant power), brain-gut axis (BGA)-related factors (vasoactive intestinal peptide [VIP], somatostatin [SS], calcitonin gene-related peptide [CGRP], serum neuropeptide S receptor 1 [NPSR1]), GF panel (pepsinogen [PG] I, PG II, gastrin [G]-17), other serum indices (motilin [MTL], 5-hydroxytryptamine [5-HT], nitric oxide [NO]), and adverse events.
Results:
According to statistics, the total effective rate was higher in the research group compared to controls, and the time to symptom improvement was shorter (P<0.05); The post-treatment gastric accommodation, dominant frequency, dominant power, NPSR1, GF panel, and MTL were higher in the research group, while VIP, SS, CGRP, 5-HT, and NO were lower (P<0.05); the total incidence of adverse reactions was equivalent across groups.
Conclusion:
The triple therapy (DPD+PB+ITP) demonstrates high therapeutic efficacy on elderly FD patients, helps improve symptoms, and actively up-regulates GF panel levels.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Pyloric Obstruction